Breaking News Instant updates and real-time market news.

GENI

Genius Sports

$6.55 /

-0.08 (-1.21%)

 06:06
01/18/22
 01/18
06:06
 01/18/22
06:06

Genius Sports secures major expansion of long-term partnership with bet365

Genius Sports has secured a major expansion of its long-term partnership with bet365. As one of the first sportsbooks to implement Genius Sports' live streaming service, bet365 has now agreed to a major uplift in the company's premium video content including low latency broadcasts from several top tier global soccer competitions and the NFL to bet365 customers outside the U.S. Genius Sports' expanded streaming solution will deliver unique new content to help enhance bet placement and customer retention for bet365. All streaming content will be combined with Genius Sports' leading portfolio of official data across thousands of events per year, including UK football and the NFL. This includes access to the fastest, most accurate data on the English Premier League as well as the NFL's real-time statistics through its proprietary Next Gen Stats. To further enhance bet365's marketing and player engagement strategy, Genius Sports will deliver its official data-driven marketing campaigns, driving deeper engagement and lower cost of acquisition across display, video and connected TV.

  • 10

    Jun

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Asur reports June traffic up 23.1% y/y, up 16.9% y/y from 2019 » 17:54
07/06/22
07/06
17:54
07/06/22
17:54
ASR

Asur

$194.30 /

+2.5 (+1.30%)

Grupo Aeroportuario del…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASR Asur
$194.30 /

+2.5 (+1.30%)

06/06/22
Asur reports May passenger traffic 5.5M, up 20.4% from May 2019
05/05/22
Asur reports total passenger traffic for April 2022
03/07/22
Asur reports February 2022 passenger traffic up 7% from February 2019
02/08/22
Asur reports January traffic up 3.3% from 2019 level
ASR Asur
$194.30 /

+2.5 (+1.30%)

02/08/22 Bradesco BBI
Asur downgraded to Neutral from Outperform at Bradesco BBI
11/30/21 Goldman Sachs
Asur upgraded to Neutral from Sell at Goldman Sachs
11/30/21 Goldman Sachs
OMA upgraded to Buy from Neutral at Goldman Sachs
10/13/21 Citi
Asur price target raised to $218 from $191 at Citi
Hot Stocks
Volaris reports June traffic results up 11% year-over-year » 17:34
07/06/22
07/06
17:34
07/06/22
17:34
VLRS

Volaris

$9.67 /

-0.105 (-1.07%)

Volaris reports June 2022…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VLRS Volaris
$9.67 /

-0.105 (-1.07%)

06/02/22
Volaris reports preliminary May traffic up 12.3%
05/04/22
Volaris reports preliminary April traffic results
04/06/22
Volaris reports March preliminary ASMs up 61.2%, RPMs up 60.4% YoY
03/03/22
Volaris reports February demand up 80.8%, capacity up 62.0%
VLRS Volaris
$9.67 /

-0.105 (-1.07%)

06:28 Today Barclays
Volaris price target lowered to $16 from $27 at Barclays
06/27/22 Evercore ISI
Volaris price target lowered to $20 from $30 at Evercore ISI
06/06/22 JPMorgan
Volaris initiated with an Overweight at JPMorgan
02/23/22 Barclays
Volaris price target raised to $27 from $25 at Barclays
VLRS Volaris
$9.67 /

-0.105 (-1.07%)

02/24/22
Volaris sees FY22 operating revenue $2.6B-$2.8B, consensus $2.43B
02/24/22
Volaris reports Q4 EBITDAR MXN5.16B, up 45%
  • 06
    Aug
07/22/22
Volaris - VLRS
Hot Stocks
General Dynamics awarded $145.47M Defense Logistics Agency contract » 17:19
07/06/22
07/06
17:19
07/06/22
17:19
GD

General Dynamics

$219.52 /

+5.235 (+2.44%)

General Dynamics has been…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GD General Dynamics
$219.52 /

+5.235 (+2.44%)

06/29/22
General Dynamics awarded $320.33M Army contract modification
06/29/22
GD NASSCO awarded $600M for U.S. Navy contract modifications
06/29/22
General Dynamics Land Systems announces LRIP award valued at $1.14B
05/26/22
General Dynamics awarded $324.52M Space Development Agency contract
GD General Dynamics
$219.52 /

+5.235 (+2.44%)

04/28/22 Susquehanna
General Dynamics price target raised to $285 from $280 at Susquehanna
03/29/22 Jefferies
Northrop among biggest beneficiaries of DoD budget request, says Jefferies
03/07/22 Wells Fargo
General Dynamics price target raised to $282 from $235 at Wells Fargo
02/04/22 Morgan Stanley
Morgan Stanley upgrades General Dynamics to Equal Weight on Gulfstream outlook
GD General Dynamics
$219.52 /

+5.235 (+2.44%)

04/27/22
General Dynamics sees Q2 EPS 10c above Q1 level, consensus $2.86
04/27/22
General Dynamics reports Q1 EPS $2.61, consensus $2.51
04/26/22
Notable companies reporting before tomorrow's open
04/26/22
Notable companies reporting before tomorrow's open
GD General Dynamics
$219.52 /

+5.235 (+2.44%)

04/19/22
Lockheed Martin in talks with Pentagon on weapons to Ukraine, WSJ reports
04/13/22
Defense contractors to meet with Pentagon to discuss Ukraine aid, FT reports
04/05/22
U.S., U.K. and Australia to co-operate on hypersonic weapons, FT says
GD General Dynamics
$219.52 /

+5.235 (+2.44%)

04/27/22
Fly Intel: Pre-market Movers
02/28/22
Fly Intel: Pre-market Movers
02/11/22
Wall Street in Fives - Must Read Lists for Friday
01/26/22
Wall Street in Fives - Must Read Lists for Wednesday
Hot Stocks
DiaMedica Therapeutics down 38% to $1.25 after placing DM199 on clinical hold  17:13
07/06/22
07/06
17:13
07/06/22
17:13
DMAC

DiaMedica Therapeutics

$2.03 /

+ (+0.00%)

 
ShowHide Related Items >><<
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

17:00 Today
DiaMedica Therapeutics trading resumes
16:49 Today
DiaMedica Therapeutics to resume trading at 17:00ET
16:34 Today
DiaMedica says FDA puts clinical hold on Phase 2/3 ReMEDy2 trial
16:28 Today
DiaMedica Therapeutics trading halted, news pending
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

03/14/22
DiaMedica Therapeutics reports Q4 EPS (65c), consensus (18c)
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

05/04/22
Meet DiaMedica Therapeutics: Fly exclusive interview with CEO Rick Pauls
08/08/22
Biotechnology Conference
Hot Stocks
Shore Bancshares authorizes up to $5M stock buyback » 17:09
07/06/22
07/06
17:09
07/06/22
17:09
SHBI

Shore Bancshares

$18.53 /

-0.02 (-0.11%)

Shore Bancshares…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHBI Shore Bancshares
$18.53 /

-0.02 (-0.11%)

11/04/21 Piper Sandler
Shore Bancshares upgraded to Overweight from Neutral at Piper Sandler
SHBI Shore Bancshares
$18.53 /

-0.02 (-0.11%)

02/14/22
Shore Bancshares reports Q4 GAAP EPS 16c , consensus 37c
Syndicate
Oil States files to sell 1.9M shares of common stock for holders  17:08
07/06/22
07/06
17:08
07/06/22
17:08
OIS

Oil States

$4.68 /

-0.23 (-4.68%)

 
ShowHide Related Items >><<
OIS Oil States
$4.68 /

-0.23 (-4.68%)

07/05/22
Oil States names Philip Moses as COO
03/07/22
Oil States rises 26.5%
OIS Oil States
$4.68 /

-0.23 (-4.68%)

04/18/22 Piper Sandler
Oil States price target raised to $10 from $8 at Piper Sandler
03/07/22 Piper Sandler
Oil States upgraded to Overweight with 45% upside at Piper Sandler
03/04/22 Piper Sandler
Oil States upgraded to Overweight from Neutral at Piper Sandler
OIS Oil States
$4.68 /

-0.23 (-4.68%)

04/28/22
Oil States reports Q1 EPS (16c), consensus (13c)
02/16/22
Oil States reports Q4 EPS (14c), consensus (13c)
Hot Stocks
China Green removed from NYSE late filers list following quarterly report » 17:02
07/06/22
07/06
17:02
07/06/22
17:02
CGA

China Green

$5.26 /

-0.885 (-14.41%)

China Green announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGA China Green
$5.26 /

-0.885 (-14.41%)

05/27/22
China Green discloses NYSE notice regarding late 10-Q filing
05/25/22
China Green falls -7.6%
05/25/22
China Green falls -8.0%
05/25/22
China Green falls -8.0%
Hot Stocks
Blackstone announces $400M investment in Xpansiv » 17:01
07/06/22
07/06
17:01
07/06/22
17:01
BX

Blackstone

$93.96 /

-0.005 (-0.01%)

Blackstone…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BX Blackstone
$93.96 /

-0.005 (-0.01%)

07/01/22
Blackstone, RiseBoro enter agreement to resructure partnership
06/30/22
Skillz appoints Jason Roswig as CFO
06/09/22
Preferred Apartment: Proxy firms urge holders to vote 'FOR" BREIT acquisition
05/19/22
Blackstone REIT completes $3.7B acquisition of Resource REIT
BX Blackstone
$93.96 /

-0.005 (-0.01%)

05/19/22 Deutsche Bank
Blackstone price target lowered to $180 from $182 at Deutsche Bank
04/27/22 Argus
American Campus downgraded to Hold from Buy at Argus
04/22/22 BMO Capital
Blackstone price target raised to $142 from $124 at BMO Capital
04/22/22 Deutsche Bank
Blackstone price target lowered to $182 from $186 at Deutsche Bank
BX Blackstone
$93.96 /

-0.005 (-0.01%)

01/27/22
Blackstone reports Q4 distributable EPS $1.71, consensus $1.37
01/26/22
Notable companies reporting before tomorrow's open
01/26/22
Notable companies reporting before tomorrow's open
  • 08
    Dec
BX Blackstone
$93.96 /

-0.005 (-0.01%)

16:15 Today
Blackstone to invest $400M in trading platform Xpansiv, WSJ reports
07/05/22
Apollo, Blackstone seek buyers for Ridgeback Resources, Reuters reports
06/22/22
Toshiba bidders could offer up to $51.41 per share in buyout, Reuters reports
06/22/22
Blackstone's Crown Resorts permitted to open Sydney casino, WSJ reports
BX Blackstone
$93.96 /

-0.005 (-0.01%)

07/05/22
What You Missed On Wall Street On Tuesday
05/26/22
What You Missed On Wall Street On Thursday
05/26/22
What You Missed On Wall Street This Morning
05/11/22
What You Missed On Wall Street On Wednesday
07/21/22
Blackstone - BX
09/29/22
Blackstone
BX Blackstone
$93.96 /

-0.005 (-0.01%)

06/28/22
Blackstone put volume heavy and directionally bearish
06/16/22
Blackstone put volume heavy and directionally bearish
06/01/22
Blackstone put volume heavy and directionally bearish
05/24/22
Blackstone put volume heavy and directionally bearish
Hot Stocks
DiaMedica Therapeutics trading resumes  17:00
07/06/22
07/06
17:00
07/06/22
17:00
DMAC

DiaMedica Therapeutics

$2.03 /

+ (+0.00%)

 
ShowHide Related Items >><<
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

16:49 Today
DiaMedica Therapeutics to resume trading at 17:00ET
16:34 Today
DiaMedica says FDA puts clinical hold on Phase 2/3 ReMEDy2 trial
16:28 Today
DiaMedica Therapeutics trading halted, news pending
05/04/22
DiaMedica CEO expects final data will be consistent with interim data from REDUX
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

03/14/22
DiaMedica Therapeutics reports Q4 EPS (65c), consensus (18c)
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

05/04/22
Meet DiaMedica Therapeutics: Fly exclusive interview with CEO Rick Pauls
08/08/22
Biotechnology Conference
Syndicate
Duckhorn Portfolio offers to sell 5M shares of common stock for holder » 16:56
07/06/22
07/06
16:56
07/06/22
16:56
NAPA

Duckhorn Portfolio

$20.72 /

-0.45 (-2.13%)

The Duckhorn Portfolio…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NAPA Duckhorn Portfolio
$20.72 /

-0.45 (-2.13%)

06/03/22
Duckhorn Portfolio rises 8.4%
06/03/22
Duckhorn Portfolio rises 6.4%
NAPA Duckhorn Portfolio
$20.72 /

-0.45 (-2.13%)

06/06/22 Barclays
Duckhorn Portfolio price target raised to $21 from $20 at Barclays
03/28/22 RBC Capital
Duckhorn Portfolio upgraded to Outperform from Sector Perform at RBC Capital
03/10/22 Barclays
Duckhorn Portfolio price target lowered to $19 from $22 at Barclays
12/17/21 JPMorgan
JPMorgan announces top 2022 stock picks in beverages, personal care
NAPA Duckhorn Portfolio
$20.72 /

-0.45 (-2.13%)

06/02/22
Duckhorn Portfolio raises FY22 EPS view to 59c-62c from 55c-58c
06/02/22
Duckhorn Portfolio reports Q3 adjusted EPS 17c, consensus 13c
03/10/22
Duckhorn Portfolio raises FY22 EPS view to 55c-58c, consensus 58c
03/10/22
Duckhorn Portfolio reports Q2 adjusted EPS 17c, consensus 15c
  • 15
    Oct
Hot Stocks
Kilroy Realty announces new onsite solar projects in California » 16:54
07/06/22
07/06
16:54
07/06/22
16:54
KRC

Kilroy Realty

$53.50 /

-1.1 (-2.01%)

Kilroy Realty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRC Kilroy Realty
$53.50 /

-1.1 (-2.01%)

06/06/22
Kilroy Realty signs leases totaling 190K square feet during Q2
03/10/22
Kilroy Realty announces acquisition of strategic Austin development site
KRC Kilroy Realty
$53.50 /

-1.1 (-2.01%)

06:41 Today Mizuho
Kilroy Realty price target lowered to $60 from $77 at Mizuho
07/05/22 RBC Capital
Kilroy Realty price target lowered to $68 from $80 at RBC Capital
06/30/22 Jefferies
Kilroy Realty price target lowered to $58 from $76 at Jefferies
06/22/22 Credit Suisse
Kilroy Realty initiated with an Underperform at Credit Suisse
KRC Kilroy Realty
$53.50 /

-1.1 (-2.01%)

04/27/22
Kilroy Realty sees FY22 FFO $4.44-$4.58, consensus $4.48
04/27/22
Kilroy Realty reports Q1 FFO $1.16, consensus $1.09
01/31/22
Kilroy Realty reports Q4 FFO $1.05, consensus 95c
KRC Kilroy Realty
$53.50 /

-1.1 (-2.01%)

05/25/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
04/22/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
07/28/22
Kilroy Realty - KRC
Hot Stocks
DiaMedica Therapeutics to resume trading at 17:00ET  16:49
07/06/22
07/06
16:49
07/06/22
16:49
DMAC

DiaMedica Therapeutics

$2.03 /

+ (+0.00%)

 
ShowHide Related Items >><<
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

16:34 Today
DiaMedica says FDA puts clinical hold on Phase 2/3 ReMEDy2 trial
16:28 Today
DiaMedica Therapeutics trading halted, news pending
05/04/22
DiaMedica CEO expects final data will be consistent with interim data from REDUX
05/04/22
Ongoing trials 'slower' due to COVID, DiaMedica CEO tells The Fly
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

03/14/22
DiaMedica Therapeutics reports Q4 EPS (65c), consensus (18c)
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

05/04/22
Meet DiaMedica Therapeutics: Fly exclusive interview with CEO Rick Pauls
08/08/22
Biotechnology Conference
Hot Stocks
Energy Services of America announces buyback for up to 1M shares of common stock » 16:46
07/06/22
07/06
16:46
07/06/22
16:46
ESOA

Energy Services of America

$2.00 /

+0.1 (+5.26%)

Energy Services of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESOA Energy Services of America
$2.00 /

+0.1 (+5.26%)

06/13/22
Summit State Bank announces Reynolds joined board of directors
03/24/22
Energy Services of America up after listing on Nasdaq Capital Market
Recommendations
Criteo price target lowered to $35 from $40 at Truist » 16:44
07/06/22
07/06
16:44
07/06/22
16:44
CRTO

Criteo

$22.93 /

-0.73 (-3.09%)

Truist analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRTO Criteo
$22.93 /

-0.73 (-3.09%)

06/16/22
Criteo 'very pleased' with FCA decision to accept commitments offered by Meta
03/03/22
Criteo unable to anticipate closing of IPONWEB deal due to Russian invasion
02/23/22
Criteo partners with Michaels for retail media advertising on Michaels.com
02/16/22
Google announces 'Privacy Sandbox on Android'
CRTO Criteo
$22.93 /

-0.73 (-3.09%)

06/29/22 JPMorgan
Criteo price target lowered to $29 from $40 at JPMorgan
06/16/22 Truist
France ruling on Meta incremental positive for Criteo, says Truist
05/02/22 Truist
Criteo price target lowered to $40 from $45 at Truist
03/03/22 Truist
Criteo price target lowered to $45 from $50 at Truist
CRTO Criteo
$22.93 /

-0.73 (-3.09%)

05/04/22
Criteo lowers FY22 revenue ex-TAC growth view to 8%-10% at constant currency
05/04/22
Criteo sees Q2 revenue ex-TAC $220M-$224M, consensus $234.21M
05/04/22
Criteo reports Q1 adjusted EPS 53c, consensus 45c
02/09/22
Criteo sees Q1 revenue ex-TAC $216M-$220M, consensus $233.41M
CRTO Criteo
$22.93 /

-0.73 (-3.09%)

04/26/22
What Wall Street is saying about Alphabet ahead of earnings
02/16/22
What You Missed On Wall Street On Wednesday
02/16/22
What You Missed On Wall Street This Morning
General News
API crude inventories for week of July 1 » 16:40
07/06/22
07/06
16:40
07/06/22
16:40
USO

United States Oil Fund

$73.62 /

-1.17 (-1.56%)

API reports that crude…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
USO United States Oil Fund
$73.62 /

-1.17 (-1.56%)

06/14/22
Freeport LNG issues update on incident at liquefaction plant on June 8
USO United States Oil Fund
$73.62 /

-1.17 (-1.56%)

03/09/22
UAE to encourage OPEC to raise oil production, FT reports
03/04/22
Biden administration mulls ban on U.S. imports of Russian crude, Bloomberg says
USO United States Oil Fund
$73.62 /

-1.17 (-1.56%)

03/04/22
What You Missed On Wall Street On Friday
02/02/22
Wall Street in Fives - Must Read Lists for Wednesday
USO United States Oil Fund
$73.62 /

-1.17 (-1.56%)

07/05/22
Unusually active option classes on open July 5th
06/22/22
Unusually active option classes on open June 22nd
Hot Stocks
Crescent Point Energy raises quarterly dividend to 8c per share from 5c » 16:38
07/06/22
07/06
16:38
07/06/22
16:38
CPG

Crescent Point Energy

$6.39 /

-0.385 (-5.68%)

The Company's Board…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPG Crescent Point Energy
$6.39 /

-0.385 (-5.68%)

05/12/22
Crescent Point now expects to generate $1.2B-$1.4B of excess cash flow in 2022
05/12/22
Crescent Point Energy raises quarterly dividend by over 40% to 6.5c per share
03/04/22
Crescent Point Energy receives TSX approval for normal course issuer bid
CPG Crescent Point Energy
$6.39 /

-0.385 (-5.68%)

06/30/22 Stifel
Crescent Point Energy price target raised to C$17 from C$15.50 at Stifel
06/16/22 National Bank
Crescent Point Energy price target raised to C$23 from C$20 at National Bank
06/15/22 CIBC
Crescent Point Energy price target raised to C$16 from C$13.50 at CIBC
06/08/22 Scotiabank
Crescent Point Energy upgraded to Outperform from Sector Perform at Scotiabank
CPG Crescent Point Energy
$6.39 /

-0.385 (-5.68%)

05/12/22
Crescent Point Energy reports Q1 adjusted EPS 41c, consensus 25c
CPG Crescent Point Energy
$6.39 /

-0.385 (-5.68%)

02/07/22
Documents show Crescent Point looking to sell some oil, gas assets, Reuters says
CPG Crescent Point Energy
$6.39 /

-0.385 (-5.68%)

06/08/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
CPG Crescent Point Energy
$6.39 /

-0.385 (-5.68%)

15:25 Today
Crescent Point Energy call volume above normal and directionally bullish
06/17/22
Crescent Point Energy call volume above normal and directionally bullish
06/14/22
Crescent Point Energy call volume above normal and directionally bullish
Hot Stocks
Reservoir Media 'commends' U.S. Copyright Royalty Board phonorecords ruling » 16:37
07/06/22
07/06
16:37
07/06/22
16:37
RSVR

Reservoir Media

$6.48 /

-0.02 (-0.31%)

Reservoir Media, Inc.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RSVR Reservoir Media
$6.48 /

-0.02 (-0.31%)

07/05/22
Reservoir Media added to Russell 2000 Index
05/10/22
Reservoir Media announces deal with Mohamed Ramadan, purchase of 100COPIES
03/29/22
Reservoir Media announces deal for catalog of Larry Kusik
03/22/22
Reservoir Media acquires rights to the catalog of composer Henry Jackman
RSVR Reservoir Media
$6.48 /

-0.02 (-0.31%)

08/23/21 Craig-Hallum
Craig-Hallum bullish on Reservoir Media, initiates with a Buy
08/23/21 Craig-Hallum
Reservoir Media initiated with a Buy at Craig-Hallum
08/23/21 Roth Capital
Reservoir Media initiated with a Buy at Roth Capital
RSVR Reservoir Media
$6.48 /

-0.02 (-0.31%)

06/21/22
Reservoir Media sees 2023 revenue $116M-$121M, consensus $118.93M
06/21/22
Reservoir Media reports Q4 EPS 14c, consensus 9c
02/08/22
Reservoir Media raises FY22 revenue view to $103M-$105M from $100M-$104M
02/08/22
Reservoir Media reports Q3 EPS 3c, three estimates 3c
RSVR Reservoir Media
$6.48 /

-0.02 (-0.31%)

06/21/22
What You Missed On Wall Street On Tuesday
06/21/22
What You Missed On Wall Street This Morning
06/21/22
Fly Intel: Pre-market Movers
03/14/22
Fly Insider: Ball Corp, Datadog among week's notable insider trades
08/15/22
Reservoir Media Inc
RSVR Reservoir Media
$6.48 /

-0.02 (-0.31%)

06/23/22
Fourteen new option listings and one option delisting on June 23rd
Periodicals
Apple plans for larger Apple Watch geared towards extreme sports, Bloomberg says » 16:36
07/06/22
07/06
16:36
07/06/22
16:36
AAPL

Apple

$142.96 /

+1.365 (+0.96%)

Apple has plans for its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$142.96 /

+1.365 (+0.96%)

07/05/22
EU regulators adopt new rules to monitor 'Tech Giants'
07/04/22
Fly Intel: Top five weekend stock stories
06/30/22
Apple's former director of corporate law admits to insider trading
06/30/22
Comcast's Xfinity Stream app launches on Apple TV 4K, Apple TV HD
AAPL Apple
$142.96 /

+1.365 (+0.96%)

07/05/22 Morgan Stanley
Apple App Store revenue grew 5% in June quarter, says Morgan Stanley
07/01/22 JPMorgan
Apple near-term estimates 'resilient' despite concerns, says JPMorgan
06/30/22 Tigress Financial
Tigress Financial reiterates Strong Buy on Apple, sees further upside in shares
06/30/22 Morgan Stanley
Morgan Stanley Asia checks 'mostly validate' Qualcomm-Apple baseband chatter
AAPL Apple
$142.96 /

+1.365 (+0.96%)

04/28/22
Apple says y/y Q3 revenue growth to be impacted by COVID
04/28/22
Apple reports Q2 EPS $1.52, consensus $1.43
04/28/22
Notable companies reporting after market close
02/27/22
Berkshire operating earnings surge, Buffett repurchases record $27B in stock
AAPL Apple
$142.96 /

+1.365 (+0.96%)

16:04 Today
Apple plans rugged sports watch with larger screen for September, Bloomberg says
14:18 Today
Apple preparing security feature to combat sophisticated spyware, WSJ says
08:11 Today
Kuo: Apple's A16 processor to be exclusive to iPhone 14 Pro, AppleInsider says
06:17 Today
Meta Platforms to continue its digital collectibles plan, FT reports
AAPL Apple
$142.96 /

+1.365 (+0.96%)

07/05/22
What You Missed On Wall Street On Tuesday
07/01/22
What You Missed On Wall Street On Friday
07/01/22
What You Missed On Wall Street This Morning
06/28/22
What You Missed On Wall Street On Tuesday
07/28/22
Apple - AAPL
AAPL Apple
$142.96 /

+1.365 (+0.96%)

08:55 Today
Notable open interest changes for July 6th
06/30/22
Notable open interest changes for June 30th
06/29/22
Notable open interest changes for June 29th
06/29/22
Apple put buyer realizes 93% same-day gains
Hot Stocks
Veru jumps another 17% after Jefferies predicts FDA authorization » 16:36
07/06/22
07/06
16:36
07/06/22
16:36
VERU

Veru

$13.03 /

+1.52 (+13.21%)

Shares of Veru, which…

Shares of Veru, which rallied 13% during the trading day to $13.02, jumped another 17% in after-hours trading to $15.39 after Jefferies predicted this morning's COVID-19 data would lead to an Emergency Use Authorization by the FDA in 30 days. Despite recent investor skepticism, the Phase 3 COVID-19 results for sabizabulin published this morning in the New England Journal of Medicine "addressed most concerns," Jefferies analyst Chris Howerton told investors in a research note. He reiterated a Buy rating on the shares with a $55 price target.

ShowHide Related Items >><<
VERU Veru
$13.03 /

+1.52 (+13.21%)

07:41 Today
Veru's sabizabulin shows reduction of COVID-19 deaths in published trial
06/07/22
Veru submits EUA application to FDA for sabizabulin
06/06/22
Tang Capital reports 5.2% passive stake in Veru
06/06/22
Veru presents final results from Phase 1b/2 study of sabizabulin
VERU Veru
$13.03 /

+1.52 (+13.21%)

16:31 Today Jefferies
Veru data likely portend FDA authorization in 30 days, says Jefferies
05/18/22 Brookline
Veru price target raised to $31 from $29 at Brookline
05/13/22 Jefferies
Veru price target raised to $55 from $33 at Jefferies
04/12/22 Oppenheimer
Veru price target raised to $36 from $25 at Oppenheimer
VERU Veru
$13.03 /

+1.52 (+13.21%)

05/12/22
Veru reports Q2 EPS (18c), consensus (15c)
02/09/22
Veru reports Q1 EPS (8c), consensus (12c)
VERU Veru
$13.03 /

+1.52 (+13.21%)

05/02/22
Culper Research says shorting Veru, sees COVID-19 EUA as 'non-starter'
04/11/22
STAT's Feuerstein asks how 45% mortality rate 'possible' in Veru placebo arm
VERU Veru
$13.03 /

+1.52 (+13.21%)

16:12 Today
What You Missed On Wall Street On Wednesday
12:01 Today
What You Missed On Wall Street This Morning
06/07/22
Fly Intel: Pre-market Movers
06/06/22
Fly Intel: After-Hours Movers
VERU Veru
$13.03 /

+1.52 (+13.21%)

06/27/22
Veru call volume above normal and directionally bullish
06/07/22
Veru call volume above normal and directionally bullish
06/07/22
Unusually active option classes on open June 7th
06/03/22
Veru call volume above normal and directionally bullish
Syndicate
Duckhorn Portfolio files automatic mixed securities shelf  16:36
07/06/22
07/06
16:36
07/06/22
16:36
NAPA

Duckhorn Portfolio

$20.72 /

-0.45 (-2.13%)

 
ShowHide Related Items >><<
NAPA Duckhorn Portfolio
$20.72 /

-0.45 (-2.13%)

06/03/22
Duckhorn Portfolio rises 8.4%
06/03/22
Duckhorn Portfolio rises 6.4%
NAPA Duckhorn Portfolio
$20.72 /

-0.45 (-2.13%)

06/06/22 Barclays
Duckhorn Portfolio price target raised to $21 from $20 at Barclays
03/28/22 RBC Capital
Duckhorn Portfolio upgraded to Outperform from Sector Perform at RBC Capital
03/10/22 Barclays
Duckhorn Portfolio price target lowered to $19 from $22 at Barclays
12/17/21 JPMorgan
JPMorgan announces top 2022 stock picks in beverages, personal care
NAPA Duckhorn Portfolio
$20.72 /

-0.45 (-2.13%)

06/02/22
Duckhorn Portfolio raises FY22 EPS view to 59c-62c from 55c-58c
06/02/22
Duckhorn Portfolio reports Q3 adjusted EPS 17c, consensus 13c
03/10/22
Duckhorn Portfolio raises FY22 EPS view to 55c-58c, consensus 58c
03/10/22
Duckhorn Portfolio reports Q2 adjusted EPS 17c, consensus 15c
  • 15
    Oct
Hot Stocks
CytomX Therapeutics trading resumes  16:35
07/06/22
07/06
16:35
07/06/22
16:35
CTMX

CytomX Therapeutics

$1.96 /

+0.015 (+0.77%)

 
ShowHide Related Items >><<
CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

16:18 Today
CytomX Therapeutics to resume trading at 4:35 pm ET
16:16 Today
CytomX reports Arm A of praluzatamab ravtansine trial met primary endpoint
16:00 Today
CytomX Therapeutics trading halted, news pending
06/16/22
CytomX Therapeutics announces new employment inducement grants
CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

06/23/22 BMO Capital
CytomX Therapeutics initiated with an Outperform at BMO Capital
05/27/22 Piper Sandler
CytomX Therapeutics price target lowered to $10 from $16 at Piper Sandler
01/18/22 Barclays
CytomX Therapeutics upgraded to Overweight from Underweight at Barclays
12/22/21 H.C. Wainwright
CytomX Therapeutics price target lowered to $11 from $12 at H.C. Wainwright
CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

03/01/22
CytomX Therapeutics reports Q4 revenue $19.7M, consensus $24.51M
08/08/22
Biotechnology Conference
Hot Stocks
DiaMedica says FDA puts clinical hold on Phase 2/3 ReMEDy2 trial » 16:34
07/06/22
07/06
16:34
07/06/22
16:34
DMAC

DiaMedica Therapeutics

$2.03 /

+ (+0.00%)

DiaMedica Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

16:28 Today
DiaMedica Therapeutics trading halted, news pending
05/04/22
DiaMedica CEO expects final data will be consistent with interim data from REDUX
05/04/22
Ongoing trials 'slower' due to COVID, DiaMedica CEO tells The Fly
05/04/22
Acute ischemic trial to be complete late 2023, early 2024, DiaMedica CEO says
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

03/14/22
DiaMedica Therapeutics reports Q4 EPS (65c), consensus (18c)
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

05/04/22
Meet DiaMedica Therapeutics: Fly exclusive interview with CEO Rick Pauls
08/08/22
Biotechnology Conference
Hot Stocks
Altisource Asset Management appoints Jason Kopcak as CEO » 16:32
07/06/22
07/06
16:32
07/06/22
16:32
AAMC

Altisource Asset Management

$10.53 /

+0.24 (+2.33%)

Altisource Asset…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAMC Altisource Asset Management
$10.53 /

+0.24 (+2.33%)

04/27/22
Altisource Asset Management announces stock purchases by directors, officers
03/18/22
Altisource Asset Management creates Aletnerative Lending Group
01/07/22
Altisource announces settlement with Series A Preferred stockholders
AAMC Altisource Asset Management
$10.53 /

+0.24 (+2.33%)

04/22/22
Altisource Asset Management reports Q1 EPS 66c vs. $37.41 last year
Recommendations
Veru data likely portend FDA authorization in 30 days, says Jefferies » 16:31
07/06/22
07/06
16:31
07/06/22
16:31
VERU

Veru

$13.03 /

+1.52 (+13.21%)

Despite recent investor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VERU Veru
$13.03 /

+1.52 (+13.21%)

07:41 Today
Veru's sabizabulin shows reduction of COVID-19 deaths in published trial
06/07/22
Veru submits EUA application to FDA for sabizabulin
06/06/22
Tang Capital reports 5.2% passive stake in Veru
06/06/22
Veru presents final results from Phase 1b/2 study of sabizabulin
VERU Veru
$13.03 /

+1.52 (+13.21%)

05/18/22 Brookline
Veru price target raised to $31 from $29 at Brookline
05/13/22 Jefferies
Veru price target raised to $55 from $33 at Jefferies
04/12/22 Oppenheimer
Veru price target raised to $36 from $25 at Oppenheimer
04/11/22 Cantor Fitzgerald
Veru's Covid data highlights multiple shots on goal, says Cantor Fitzgerald
VERU Veru
$13.03 /

+1.52 (+13.21%)

05/12/22
Veru reports Q2 EPS (18c), consensus (15c)
02/09/22
Veru reports Q1 EPS (8c), consensus (12c)
VERU Veru
$13.03 /

+1.52 (+13.21%)

05/02/22
Culper Research says shorting Veru, sees COVID-19 EUA as 'non-starter'
04/11/22
STAT's Feuerstein asks how 45% mortality rate 'possible' in Veru placebo arm
VERU Veru
$13.03 /

+1.52 (+13.21%)

16:12 Today
What You Missed On Wall Street On Wednesday
12:01 Today
What You Missed On Wall Street This Morning
06/07/22
Fly Intel: Pre-market Movers
06/06/22
Fly Intel: After-Hours Movers
VERU Veru
$13.03 /

+1.52 (+13.21%)

06/27/22
Veru call volume above normal and directionally bullish
06/07/22
Veru call volume above normal and directionally bullish
06/07/22
Unusually active option classes on open June 7th
06/03/22
Veru call volume above normal and directionally bullish
Hot Stocks
First Bancshares receives regulatory approval for Beach Bancorp merger » 16:31
07/06/22
07/06
16:31
07/06/22
16:31
FBMS

First Bancshares

$28.69 /

-0.42 (-1.44%)

The First Bancshares…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FBMS First Bancshares
$28.69 /

-0.42 (-1.44%)

04/26/22
First Bancshares raises dividend 6% to 18c
03/09/22
First Bancshares authorizes new share repurchase program
02/08/22
First Bancshares announces renewal of share repurchase plan
FBMS First Bancshares
$28.69 /

-0.42 (-1.44%)

04/26/22
First Bancshares reports Q1 EPS 81c, consensus 72c
04/26/22
First Bancshares to acquire Beach Bancorp
01/26/22
First Bancshares reports Q4 EPS 76c, consensus 75c

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.